OR WAIT null SECS
November 02, 2017
Ralph Gosden, head of product development at Catalent’s Swindon, United Kingdom site, explains the opportunities of orally disintegrating tablets as a patient-centric dosage form.
Pharmaceutical companies are increasingly adopting patient-centric formulation development to ensure that drug products adequately meet the needs of end-users in all target patient populations.
Taste masking increases drug acceptability and medication adherence in pediatric, geriatric, and other special patient populations.
Model-based formulation and technology selection methodologies facilitate rapid product development.
November 01, 2017
The pharmaceutical packaging and drug delivery conference has announced its event program taking place on Feb. 7–8, 2018 at Paris Expo Porte de Versailles in France.
October 27, 2017
The vaccine is approved for the prevention of shingles in adult patients aged 50 years and older.
AbbVie will pay a $205-million upfront payment and have the option to develop and commercialize two antibody targets globally.
October 26, 2017
The new BioLive event, which will be a global hub for biopharmaceutical manufacturing, will launch alongside CPhI Worldwide 2018 in Madrid.
Inovio has reported results from a study with non-human primates that showed 100% effectiveness with a DNA vaccine the company is developing with the US Army.
October 25, 2017
ABEC, an equipment and engineering company, will provide a custom-made, single-use bioreactor to custom manufacturing firm, Emergent, for its Maryland manufacturing facility.